Cargando…
Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia
The use of oncolytic viruses has emerged as a promising therapeutic approach due to the features of these viruses, which selectively replicate and destroy tumor cells while sparing normal cells. Although numerous oncolytic viruses have been developed for testing in solid tumors, only a few have been...
Autores principales: | Wang, Zixuan, Liu, Wenmo, Wang, Lizheng, Gao, Peng, Li, Zhe, Wu, Jiaxin, Zhang, Haihong, Wu, Hui, Kong, Wei, Yu, Bin, Yu, Xianghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181830/ https://www.ncbi.nlm.nih.gov/pubmed/32327638 http://dx.doi.org/10.1038/s41392-020-0135-9 |
Ejemplares similares
-
A tropism-transformed Oncolytic Adenovirus with Dual Capsid Modifications for enhanced Glioblastoma Therapy
por: Wang, Lizheng, et al.
Publicado: (2020) -
A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route
por: Wang, Zhen, et al.
Publicado: (2016) -
Dose-related immunomodulatory effects of recombinant TRAIL in the tumor immune microenvironment
por: Wang, Xupu, et al.
Publicado: (2023) -
Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression
por: Wang, Lizheng, et al.
Publicado: (2017) -
Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity
por: Wang, Lizheng, et al.
Publicado: (2017)